Bristol-Myers Inks $10.8M Deal In Direct Buyers' Antitrust Suit

By Lauren Berg · June 6, 2022, 7:13 PM EDT

A California federal judge gave his blessing Friday to a $10.8 million settlement resolving direct buyers' claims alleging Bristol-Myers Squibb engaged in anti-competitive conduct to block generics competition and keep HIV medication...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

KPH Healthcare Services, Inc. v. Gilead Sciences, Inc. et al

Case Number

3:20-cv-06961

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

October 06, 2020